Emendo Biotherapeutics
Cambridge, United States· Est. 2014
EmendoBio is boldly evolving traditional CRISPR solutions to make a positive impact on human health and previously incurable diseases.
Private Company
Total funding raised: $157M
About
EmendoBio is boldly evolving traditional CRISPR solutions to make a positive impact on human health and previously incurable diseases.
Genetics & Genomics
Funding History
2Total raised:$157M
Series B$96MDec 15, 2021
Series A$61MJan 15, 2020